Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (original) (raw)

References

1. Chambers, C.A. & Allison, J.P. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9, 396–404 (1997).
   Article CAS PubMed Google Scholar
2. Lenschow, D.J., Walunas, T.L. & Bluestone, J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233–258 (1996).
   Article CAS PubMed Google Scholar
3. Chen, L., Linsley, P.S. & Hellstrom, K.E. Costimulation of T cells for tumor immunity. Immunol. Today 14, 483–486 (1993).
   Article CAS PubMed Google Scholar
4. Boise, L.H., Noel, P.J. & Thompson, C.B. CD28 and apoptosis. Curr. Opin. Immunol. 7, 620–625 (1995).
   Article CAS PubMed Google Scholar
5. Watts, T.H. & DeBenedette, M.A. T cell co-stimulatory molecules other than CD28. Curr. Opin. Immunol. 11, 286–293 (1999).
   Article CAS PubMed Google Scholar
6. Noel, P.J., Boise, L.H., Green, J.M. & Thompson, C.B. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157, 636–642 (1996).
   CAS PubMed Google Scholar
7. Hurtado, J.C., Kim, Y.J. & Kwon, B.S. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J. Immunol. 158, 2600–2609 (1997).
   CAS PubMed Google Scholar
8. Takahashi, C., Mittler, R.S. & Vella, A.T. 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162, 5037–5040 (1999).
   CAS PubMed Google Scholar
9. Rogers, P.R., Song, J., Gramaglia, I., Killeen, N. & Croft, M. OX40 promotes bcl-xl and bcl-2 expression and is essential for long-term survival of CD4+ T cells. Immunity 15, 445–455 (2001).
   Article CAS PubMed Google Scholar
10. Krummel, M.F. & Allison, J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533–2540 (1996).
    Article CAS PubMed Google Scholar
11. Walunas, T.L., Bakker, C.Y. & Bluestone, J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541–2550 (1996).
    Article CAS PubMed Google Scholar
12. Dong, H., Zhu, G., Tamada, K. & Chen, L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nature Med. 5, 1365–1369 (1999).
    Article CAS PubMed Google Scholar
13. Tamura, H. et al. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97, 1809–1816 (2001).
    Article CAS PubMed Google Scholar
14. Freeman, G.J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027–1034 (2000).
    Article CAS PubMed PubMed Central Google Scholar
15. Nishimura, H., Nose, M., Hiai, H., Minato, N. & Honjo, T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif–carrying immunoreceptor. Immunity 11, 141–151 (1999).
    Article CAS PubMed Google Scholar
16. Nishimura, H. et al. Autoimmune dilated cardiomyopathy in PD-1 receptor–deficient mice. Science 291, 319–322 (2001).
    Article CAS PubMed Google Scholar
17. Rivoltini, L. et al. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res. 55, 3149–3157 (1995).
    CAS PubMed PubMed Central Google Scholar
18. Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449–1456 (1995).
    Article CAS PubMed Google Scholar
19. Jeremias, I., Herr, I., Boehler, T. & Debatin, K.M. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 28, 143–152 (1998).
    Article CAS PubMed Google Scholar
20. Zhao, S. et al. Functional expression of TRAIL by lymphoid and myeloid tumour cells. Br. J. Haematol. 106, 827–832 (1999).
    Article CAS PubMed Google Scholar
21. Lu, J. & Celis, E. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes. Cancer Res. 60, 5223–5227 (2000).
    CAS PubMed Google Scholar
22. Georgescu, L., Vakkalanka, R.K. Elkon, K.B. & Crow, M.K. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest. 100, 2622–2633 (1997).
    Article CAS PubMed PubMed Central Google Scholar
23. Sykulev, Y. et al. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA 91, 11487–11491 (1994).
    Article CAS PubMed PubMed Central Google Scholar
24. Tamada, K., Tamura, H., Flies, D.B., Fu, Y.X., Pease, L.R., Blazar, B.R. & Chen, L. Blockade of LIGHT/LTβ and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease. J. Clin. Invest. 109, 549–557 (2002).
    Article CAS PubMed PubMed Central Google Scholar
25. Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellstrom, I. & Hellstrom, K.E. Tumor immunogenicity determines the effect of B7 costimulation on T cell–mediated tumor immunity. J. Exp. Med. 179, 523–532 (1994).
    Article CAS PubMed Google Scholar
26. Smyth, M.J., Godfrey, D.I. & Trapani, J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunol. 2, 293–299 (2001).
    Article CAS Google Scholar
27. Griffith, T.S, Brunner, T., Fletcher, S.M., Green, D.R. & Ferguson, T.A. Fas ligand–induced apoptosis as a mechanism of immune privilege. Science 270, 1189–1192 (1995).
    Article CAS PubMed Google Scholar
28. O'Connell, J., Bennett, M.W., O'Sullivan, G.C., Collins, J.K. & Shanahan, F. Fas counter-attack: the best form of tumor defense? Nature Med. 5, 267–268 (1999).
    Article CAS PubMed Google Scholar
29. Strand, S. & Galle, P.R. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications. Mol. Med. Today 4, 63–68 (1998).
    Article CAS PubMed Google Scholar
30. Chappell, D.B, Zaks, T.Z., Rosenberg, S.A. & Restifo, N.P. Human melanoma cells do not express Fas (Apo-1/CD95) ligand. Cancer Res. 59, 59–62 (1999).
    CAS PubMed PubMed Central Google Scholar
31. Arai, H., Gordon, D., Nabel, E.G. & Nabel, G.J. Gene transfer of Fas ligand induces tumor regression in vivo. Proc. Natl. Acad. Sci. USA. 94, 13862–13867 (1997).
    Article CAS PubMed PubMed Central Google Scholar
32. Nakashima, M., Sonoda, K. & Watanabe, K. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen, RCAS1. Nature Med. 5, 938–942 (1999).
    Article CAS PubMed Google Scholar
33. Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887–3895 (1992).
    Article CAS PubMed PubMed Central Google Scholar
34. Linsley, P.S., Greene, J.L., Brady, W., Bajorath, J., Ledbetter, J.A. & Peach, R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793–801 (1994).
    Article CAS PubMed Google Scholar
35. Agata, Y. et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8, 765–772 (1996).
    Article CAS PubMed Google Scholar
36. Finger, L.R. et al. G The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors. Gene 197, 177–187 (1997).
    Article CAS PubMed Google Scholar
37. Chapoval, A.I., Zhu, G. & Chen, L. Immunoglobulin fusion protein as a tool for evaluation of T-cell costimulatory molecules. Methods Mol. Med. 45, 247–255 (2000).
    CAS PubMed Google Scholar
38. Kobayashi, H., Wood, M., Song, Y., Appella, E. & Celis, E. Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen. Cancer Res. 60, 5228–5236 (2000).
    CAS PubMed Google Scholar
39. Yu, Z., Kryzer, T.J., Griesmann, G.E., Kim, K.K., Benarroch, E., & Lennon, V.A. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann. Neurol. 49, 146–154 (2001).
    Article CAS PubMed Google Scholar

Download references